Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index
about
Molecular functions of thyroid hormones and their clinical significance in liver-related diseasesThyroid Hormone Mimetics: the Past, Current Status and Future ChallengesSynthesis of nucleoside phosphate and phosphonate prodrugsThyroid hormone analogues for the treatment of metabolic disorders: new potential for unmet clinical needs?New avenues for regulation of lipid metabolism by thyroid hormones and analogsProdrugs of phosphonates and phosphates: crossing the membrane barrierCross-talk between the thyroid and liver: a new target for nonalcoholic fatty liver disease treatmentThe thyroid receptor modulator KB3495 reduces atherosclerosis independently of total cholesterol in the circulation in ApoE deficient miceThe liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in miceThe amelioration of hepatic steatosis by thyroid hormone receptor agonists is insufficient to restore insulin sensitivity in ob/ob miceThyroid hormone actions are temperature-specific and regulate thermal acclimation in zebrafish (Danio rerio)The thyromimetic T-0681 protects from atherosclerosis.Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulationThyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner.Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review.Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance.In vivo selective expression of thyroid hormone receptor α1 in endothelial cells attenuates myocardial injury in experimental myocardial infarction in mice.Regulation of fatty acid composition and lipid storage by thyroid hormone in mouse liver.Impaired metabolic effects of a thyroid hormone receptor beta-selective agonist in a mouse model of diet-induced obesity.Mechanisms of thyroid hormone actionThe resurgence of thyromimetics as lipid-modifying agents.Thyroid hormones and thyroid hormone receptors: effects of thyromimetics on reverse cholesterol transport.In vivo activity of the thyroid hormone receptor beta- and α-selective agonists GC-24 and CO23 on rat liver, heart, and brain.Thyroid hormone potentiates insulin signaling and attenuates hyperglycemia and insulin resistance in a mouse model of type 2 diabetesA TRbeta-selective agonist confers resistance to diet-induced obesity.Thyroid hormone analogues and derivatives: Actions in fatty liverResponsiveness to thyroid hormone and to ambient temperature underlies differences between brown adipose tissue and skeletal muscle thermogenesis in a mouse model of diet-induced obesity.Hepatic organic anion transporting polypeptide transporter and thyroid hormone receptor interplay determines cholesterol and glucose homeostasis.3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats.Thyroid hormone status regulates the expression of secretory phospholipasesThyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor.Nuclear receptors reverse McGarry's vicious cycle to insulin resistance.In uncontrolled diabetes, thyroid hormone and sympathetic activators induce thermogenesis without increasing glucose uptake in brown adipose tissue.The Relationship between Type 2 Diabetes Mellitus and Related Thyroid Diseases.Hepatocellular carcinoma: thyroid hormone promotes tumorigenicity through inducing cancer stem-like cell self-renewal.Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways.Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys.3,5,3'-Triiodo-L-Thyronine- and 3,5-Diiodo-L-Thyronine- Affected Metabolic Pathways in Liver of LDL Receptor Deficient Mice.American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models.Thyromimetics: a review of recent reports and patents (2004 - 2009).
P2860
Q21284820-C87500CB-3DD4-40D1-866B-B57C069E337BQ26765178-D38C8102-6231-450B-87EE-93EF34EF315FQ26865400-134C9A94-0756-4366-A103-79133E54A448Q26995671-67E01843-DBF4-4DDF-8CD2-BC7B35A5B5AEQ27003043-FBA6C79A-6AC5-4719-BB0C-5CE591E18CF3Q27005712-548D9A14-5EDA-4546-945B-C9C94D443F48Q27011338-7FE52224-96FA-4C73-89CE-C8799807A29DQ27303091-E6AAC7C1-1096-4AA3-A93A-0D5F764030B6Q28472536-2CCDD9E3-9FCF-43EE-9900-0F5D49427196Q28545792-C48BFF7B-D93C-4EFC-9328-39F3C4E0AB1EQ28708830-6DFC3F39-5D07-4001-8068-2A294A3C6993Q30481717-C5C6193E-4979-4E70-A0BA-596F015538AEQ33699311-E0E0F867-239C-4D4E-8258-A5507EA1AC0CQ33825136-D30530E5-0415-4F13-A3D1-0D433DB41658Q33845489-958415D6-EEF6-4F28-8CA5-61AC5DCC4B55Q33884666-7A256185-90C3-4DA5-A445-C005557AECA9Q34001618-25FE3149-C545-434A-9E67-6F3812B754E2Q34012181-97614194-497F-40FE-BF56-C108DF23C55EQ34137115-73C2557C-9B4B-4A13-91C0-AB5DFF6D5617Q34297363-18607C93-2C3C-40DB-9697-D10A76F86DD6Q34356921-36E5AAF9-2923-4CE9-8DC7-EC7F7EEAFDCEQ34428756-BBD9BA1D-3BAA-4A88-BD2B-AEE2AE2079BEQ34578566-7F162145-6C2A-4723-8BAC-33979B4CB089Q34583551-A3C34F22-962E-4DE1-A1B8-D09194E00649Q35097051-FDFD4670-1C60-406F-AA4D-CD671BA0E7FFQ35132642-3F307C30-232A-435C-86E8-E15B2B64FC6AQ35175702-446DD1A8-E946-4FA5-9543-C682744E7F9FQ35188657-86BE8C70-B565-4333-B452-44F6F1A8C4CAQ35814769-AC9E4062-1EA0-4856-B770-85BF5ADED100Q36394788-C5EE2998-F0F0-4695-85CC-7F9DBE08D919Q36439563-821D04BE-9D7B-415A-AAB9-784293AB7101Q36732028-EAFC013B-6698-4162-B2AC-C940CFC00FF6Q36763949-AFB08C0D-EC43-4AD9-B09E-4ADE3670A328Q36825689-54843C5E-8D7F-42F8-B603-36DBE7AA1CDFQ36898047-CE9F103C-1647-4B22-822C-B1C08BD079F4Q37051093-F64A1A83-788A-4EAE-9E10-7E33BE5F533CQ37230659-2D232661-802B-4FB3-BE11-4472194AF353Q37418674-4C797B34-6688-4F3E-8080-0B1CA98C9CD7Q37460346-B23B2D5E-E63A-45EC-9048-B5C68EAC1D89Q37680964-C08C85B9-F6D1-4E0A-BCBD-2943F1E7F5F9
P2860
Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index
description
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 2007
@ast
im September 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/09/25)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/09/25)
@nl
наукова стаття, опублікована у вересні 2007
@uk
name
Targeting thyroid hormone rece ...... improves the therapeutic index
@ast
Targeting thyroid hormone rece ...... improves the therapeutic index
@en
Targeting thyroid hormone rece ...... improves the therapeutic index
@nl
type
label
Targeting thyroid hormone rece ...... improves the therapeutic index
@ast
Targeting thyroid hormone rece ...... improves the therapeutic index
@en
Targeting thyroid hormone rece ...... improves the therapeutic index
@nl
prefLabel
Targeting thyroid hormone rece ...... improves the therapeutic index
@ast
Targeting thyroid hormone rece ...... improves the therapeutic index
@en
Targeting thyroid hormone rece ...... improves the therapeutic index
@nl
P2093
P2860
P3181
P356
P1476
Targeting thyroid hormone rece ...... improves the therapeutic index
@en
P2093
Bao-Hong Zhang
Bruce R. Ito
David L. Linemeyer
Edward E. Cable
Hongjian Jiang
James M. Fujitaki
Jinzhao Hou
Mark D. Erion
Patricia D. Finn
Paul D. van Poelje
P2860
P304
15490–15495
P3181
P356
10.1073/PNAS.0702759104
P407
P577
2007-09-25T00:00:00Z